BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Advanced Bio-Surfaces, Inc. The OrthoGlide(TM) Medial Knee Implant Continues to be Accepted as an Alternative to Total Knee Replacement


11/6/2007 10:15:29 AM

MINNEAPOLIS, Nov. 6 /PRNewswire/-- Advanced Bio-Surfaces, Inc., (ABS) an orthopedic implant developer and manufacturer, announced today the OrthoGlide Medial Knee Implant has been implanted in more than 300 patients in the USA. The OrthoGlide implant is a minimally invasive device intended to relieve pain caused by moderate osteoarthritis of the knee.

"The interest from surgeons and patients for a minimally invasive alternative to the current knee replacement options on the market continues to expand," said Dr. Jeff Felt, Chairman of Advanced Bio-Surfaces. "We have increased the number of training sites in the United States in an effort to accommodate the number of interested surgeons. As the surgeon community learns more about the product and its minimal surgical approach, they understand the need for the OrthoGlide implant as a viable option for some patients. The growth is inspired by surgeons who want to be trained on a procedure that can be positioned as an alternative to total knee replacement."

In addition to training and supporting the orthopedic surgeon community interested in the OrthoGlide implant, ABS is also involved in a clinical study. This week, during the American College of Rheumatology's annual meeting in Boston, MA, William Arnold, M.D. will present data from the study that supports the OrthoGlide's clinical effectiveness. The presentation will be held in Room 153 of the Boston Convention and Exhibit Center at 5:30 p.m. on Saturday, November 10th.

About Advanced Bio-Surfaces, Inc.

ABS is a privately held company dedicated to the development of innovative joint restoration products. The company's first product, the OrthoGlide Medial Knee Implant, is intended for the treatment of patients with moderate osteoarthritis of the medial compartment. The company received 510(k) clearance to market from the U.S. Food and Drug Administration (FDA) and CE mark notification from its Notified Body, in February 2006. For additional information contact ABS at 952.912.5400 or visit the website at http://www.advbiosurf.com.

CONTACT: Robert Siegfried, VP, Finance and Administration of Advanced
Bio-Surfaces, Inc., +1-952-912-5400

Web site: http://www.advbiosurf.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES